Fitness Ozempic, Wegovy: India’s cheap weight-loss drugs could reshape global obesity fight Published 3 months ago on March 18, 2026 By News24x7 Share Tweet With India’s semaglutide patent expiring on 20 March, about 50 branded generics are expected to enter the market. Related Topics: Up Next ‘Club vibes without the hangover’: The twenty-somethings going out – in the gym Don't Miss Jersey woman felt ‘responsibility’ to share diabetes diagnosis Continue Reading Latest Horoscope2 hours ago Client Challenge Horoscope2 hours ago Google News Horoscope2 hours ago Google News Horoscope2 hours ago Google News Horoscope2 hours ago Google News Horoscope2 hours ago Google News Horoscope2 hours ago Aquarius Horoscope Today: June 10, 2026 Travel3 hours ago Names in the News 6-10-26 – Business Travel Executive Sports4 hours ago Marco Silva: Ex-Fulham manager agrees to become Benfica boss as Jose Mourinho leaves for Real Madrid Bussiness4 hours ago How to enjoy the World Cup – and keep your boss on side